Dr E. Christine Siepl

Project Lead, Somatropin Biopartners

Having led the successful EMA submission and registration of the company's sustained-release growth hormone Somatropin Biopartners, Dr. Siepl re-joined Biopartners in February 2016, with responsibility for all activities relating to Somatropin Biopartners.

Employed in the pharmaceutical industry since 1990, Dr. Siepl has accumulated broad experience in the drug development process: with an organisationally and culturally diverse range of companies; through all phases of clinical development; and in a variety of therapeutic areas.

Dr. Siepl holds a Dr. rer. nat. from the Leibnitz University of Hannover, Germany.

Back to Management Team